Aerie Pharmaceuticals Announces Appointment of Jeffrey Calabrese, CPA, as Director of Accounting

74

DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye today announced the appointment of Jeffrey Calabrese, CPA, as Director of Accounting, reporting to Christopher Staten, Aerieā€™s Vice President of Finance. Mr. Calabrese will lead external financial…

 

 

 

 

 

http://www.businesswire.com/news/home/20190617005001/en/Aerie-Pharmaceuticals-Announces-Appointment-Jeffrey-Calabrese-CPA